Evaluation of adalimumab biosimilar in treatment of psoriatic arthritis with concomitant moderate to severe chronic plaque psoriasis: An open-labeled, prospective, pilot case series.
J Am Acad Dermatol
; 83(1): 248-251, 2020 Jul.
Article
en En
| MEDLINE
| ID: mdl-32087993
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Psoriasis
/
Artritis Psoriásica
/
Biosimilares Farmacéuticos
/
Adalimumab
Tipo de estudio:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
País/Región como asunto:
Asia
Idioma:
En
Revista:
J Am Acad Dermatol
Año:
2020
Tipo del documento:
Article